相关实验视频
Updated: Jul 23, 2025

09:55
Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
990
动脉样硬化和其他相关动脉疾病
Luis M Blanco-Colio1,2, Jose L Martín-Ventura1,2,3
1Vascular Reseach Laboratory, IIS-Fundación Jiménez Díaz., Av. Reyes Católicos 2, 28040 Madrid, Spain.
International journal of molecular sciences
|July 14, 2023
概括
心血管疾病 (CVD) 是全球主要的健康问题,每年造成数百万人的死亡. 了解心血管疾病对公共卫生和医学研究至关重要.
科学领域:
- 心脏病学和公共卫生
背景情况:
- 心血管疾病 (CVD) 构成了全球重大健康负担,导致大量的发病率和死亡率.
- 全球每年有超过1700万人死于心血管疾病,这凸显了迫切需要有效的预防和治疗策略.
研究的目的:
- 为了强调心血管疾病的全球影响.
- 强调对心血管疾病的研究和干预的需要.
- 提供有关心血管健康当前状况的概述.
主要方法:
- 全球卫生统计的文献综述.
- 分析与心血管疾病相关的发病率和死亡率数据.
- 综合有关心血管健康趋势的现有研究.
主要成果:
- 心血管疾病对全球死亡率的很大一部分负责.
- 心血管疾病的发病率仍然令人担忧地高.
- 心血管疾病发病率存在显著的区域差异.
结论:
- 迫切需要采取全球行动,打击心血管疾病.
- 对预防和治疗心血管疾病的进一步研究至关重要.
- 公共卫生倡议必须优先考虑心血管健康教育和获得护理.
相关概念视频
Atherosclerosis I: Introduction
11
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Peripheral Artery Disease I: Introduction
10
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
10
Atherosclerosis IV: Nursing Management
23
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
23
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13

